Faron Pharmaceuticals Oy (DI) (FARN) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Jun 2022 12:00 PM
RNS
Faron notice of EGM
15 Jun 2022 07:00 AM
RNS
Faron Announces Top-Line 12-Month Survival Results
08 Jun 2022 07:00 AM
RNS
First Patient Dosed in Ph I/II BEXMAB Combo Study
01 Jun 2022 07:00 AM
RNS
Exercise of options
30 May 2022 07:00 AM
RNS
Presentation of Biomarker Analysis at ASCO
16 May 2022 07:00 AM
RNS
FDA and FIMEA approve BEXMAB study to begin
12 May 2022 03:50 PM
RNS
Ex Vivo Data Presented at EHA2022 Congress
09 May 2022 07:00 AM
RNS
Mol Cancer Ther Publishes Bexmarilimab Research
04 May 2022 11:15 AM
RNS
Grant of options
22 Apr 2022 01:01 PM
RNS
Board Changes
22 Apr 2022 01:00 PM
RNS
Results of AGM
21 Apr 2022 04:30 PM
RNS
Faron Presents Melanoma Data at EADO
08 Apr 2022 03:45 PM
RNS
Managers' Transactions
05 Apr 2022 07:00 AM
RNS
Faron Closes HIBISCUS Trial
25 Mar 2022 09:00 AM
RNS
Notice of Faron Pharmaceuticals Ltd's AGM
25 Mar 2022 07:15 AM
RNS
Faron´s Annual Report 2021 Published
25 Mar 2022 07:00 AM
RNS
Financial Statement January 1 to December 31 2021
14 Mar 2022 07:00 AM
RNS
Faron Publishes Research From INTEREST Trial
09 Mar 2022 07:00 AM
RNS
Presentation of Biomarker Data at AACR 2022
07 Mar 2022 07:00 AM
RNS
Notice of 2021 Full-Year Results and Annual Report
04 Mar 2022 07:00 AM
RNS
Faron presents at upcoming conferences
28 Feb 2022 05:45 PM
RNS
Faron Board Issues Warrants to IPF Partners
28 Feb 2022 07:00 AM
RNS
Faron Obtains Debt Funding from IPF Partners
23 Feb 2022 07:00 AM
RNS
Faron Updates on Bexmarilimab Development Program
14 Feb 2022 07:00 AM
RNS
Faron Announces R&D Day
03 Feb 2022 10:40 AM
RNS
Scientific Reports Publishes INFORAAA Results
31 Jan 2022 01:30 PM
RNS
Holdings in Company
31 Jan 2022 07:00 AM
RNS
Juho Jalkanen Appointed Chief Operating Officer
28 Jan 2022 07:00 AM
RNS
Grant of options
24 Jan 2022 07:00 AM
RNS
Faron at Proactive One2One Investor Forum
17 Jan 2022 07:00 AM
RNS
Faron to Present at Redeye Fight Cancer Seminar
05 Jan 2022 07:00 AM
RNS
Faron to Present at H.C. Wainwright BioConnect
04 Jan 2022 07:00 AM
RNS
Faron Appoints Marie-Louise Fjällskog as CMO
21 Dec 2021 07:00 AM
RNS
Faron's financial calendar for 2022
09 Dec 2021 07:00 AM
RNS
Faron Announces Topline MATINS Biomarker Analysis
01 Dec 2021 07:00 AM
RNS
Change in Faron's Management Team
16 Nov 2021 07:00 AM
RNS
Faron to Present at Jefferies Conference 2021
09 Nov 2021 07:00 AM
RNS
Faron awarded EUR 3.8 Million in Arbitration Case
03 Nov 2021 03:55 PM
RNS
Cellular and Molecular Life Sciences Publication
07 Oct 2021 07:00 AM
RNS
Exercise of options
05 Oct 2021 11:30 AM
RNS
Holding(s) in Company
01 Oct 2021 02:00 PM
RNS
Registration of Placing Shares with Trade Register
01 Oct 2021 07:00 AM
RNS
Results of Placing and Issue Price
30 Sep 2021 04:31 PM
RNS
Proposed Issue and Placing of Shares
17 Sep 2021 07:00 AM
RNS
Presentation of Updated MATINS Data at ESMO
09 Sep 2021 07:00 AM
RNS
Faron Announces Presentation at ESMO Congress
07 Sep 2021 07:00 AM
RNS
Faron to Present at H.C. Wainwright Conference
26 Aug 2021 07:00 AM
RNS
Half-Year Financials, January 1 - June 30 2021
25 Aug 2021 07:00 AM
RNS
First Patient Dosed in Phase II/III COVID-19 Trial
28 Jul 2021 07:00 AM
RNS
Notice of Half-Year Report
UK 100

Latest directors dealings